CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...
Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...
The recent federal reforms to pharmacy benefit managers are a meaningful step in the right direction, but the work is not ...
PrimeRx reports that independent pharmacies struggle to compete with big retailers like CVS and Walgreens due to pricing ...
Explore US health insurance stocks, key managed care risks, Medicare Advantage pressure, and major healthcare names shaping ...
When 22-year-old Cole Schmidtknecht walked up to the pharmacy counter, he learned his Advair Diskus inhaler had jumped from under $70 to over $500. He walked away without the medicine. Within a week, ...
While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust ...
In a reversal from last year, CVS will begin covering Eli Lilly's Zepbound and Foundayo in its standard prescription plan, a ...
Growth, not yield, is the deciding factor.
The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...
“With the introduction of the $199 retail pharmacy cash option and CVS progressing through the final stages of its approval process, we believe that the proportion of covered lives with access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results